|
Reverse acquisition - Net identifiable liabilities (Details) (Exchange Agreement (the "Reverse Acquisition"), DelMar Pharmaceuticals (BC) Ltd., USD $)
|
Jan. 25, 2013
|
|---|---|
|
Exchange Agreement (the "Reverse Acquisition") | DelMar Pharmaceuticals (BC) Ltd.
|
|
| Schedule Of Reverse Acquisition [Line Items] | |
| Net liabilities (derivative liability) | $ 2,041,680 |